| With the sales volume of 25.7 bln USD in 2018 and stable growth rates, the pharma market of the EAEU offers many opportunities for drug exporters. Since EAEU members agreed on unification of the regulative environment in 2016, the market entered into the transition stage with the goal to create a unified market of pharmaceuticals with single admission criteria, control measures and mutual recognition of trials conducted in any of the member states. |
